chr3-191278134-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_198152.5(UTS2B):c.140G>A(p.Arg47His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00005 in 1,559,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_198152.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.140G>A | p.Arg47His | missense_variant | 6/9 | ENST00000340524.10 | NP_937795.2 | |
UTS2B | XM_017006091.2 | c.140G>A | p.Arg47His | missense_variant | 5/8 | XP_016861580.1 | ||
UTS2B | XM_011512631.3 | c.140G>A | p.Arg47His | missense_variant | 5/8 | XP_011510933.1 | ||
UTS2B | XM_047447899.1 | c.140G>A | p.Arg47His | missense_variant | 5/8 | XP_047303855.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTS2B | ENST00000340524.10 | c.140G>A | p.Arg47His | missense_variant | 6/9 | 2 | NM_198152.5 | ENSP00000340526 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151818Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000529 AC: 11AN: 207910Hom.: 0 AF XY: 0.0000616 AC XY: 7AN XY: 113562
GnomAD4 exome AF: 0.0000455 AC: 64AN: 1407948Hom.: 0 Cov.: 27 AF XY: 0.0000486 AC XY: 34AN XY: 700188
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151818Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74118
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at